Establishing secure connection…Loading editor…Preparing document…

Healthcare Sponsor CDA

This template is fully customizable. Edit the text, fill out the fields, and send it for signature. Give it a try!

HEALTHCARE SPONSOR CONFIDENTIALITY AND DATA ACCESS AGREEMENT

This Confidentiality and Data Access Agreement (the Agreement) is entered into by and between:

Sponsor Name:     Healthcare Provider / Institution Name:

Effective Date:

Recitals

WHEREAS, Sponsor desires access to certain clinical and administrative data maintained by the Healthcare Provider for the purpose of clinical research, regulatory submissions, or aggregate analysis as described in this Agreement; and

WHEREAS, Healthcare Provider is willing to disclose such data under the terms set forth in this Agreement and consistent with applicable law, including privacy and data protection requirements.

Definitions

"Confidential Information" means non-public information disclosed by one party to the other, whether oral, written or electronic, including without limitation proprietary business information, study protocols, datasets, and patient-level health information not in the public domain.

"Personal Data" or "Protected Health Information (PHI)" means individually identifiable health information as defined under applicable law. To the extent any PHI is disclosed, Provider shall document lawful basis and patient authorization as required hereunder.

"De-identified Data" means data from which identifiers have been removed in accordance with a de-identification methodology described by the parties and consistent with applicable law so that the data cannot reasonably be used to re-identify an individual.

Scope of Data Transfer

The Healthcare Provider will disclose the following categories of data to Sponsor. Sponsor represents that use of the data will be limited to the Permitted Uses specified in this Agreement.

Data Categories (select applicable):
De-identified data (no direct identifiers)    Limited PHI dataset (as agreed)    Patient-level identified data (only where authorized)

Dataset Description:

Patient Information (Representative Record)

If specific patient records are to be transferred, identify a representative record below. Provider shall not transfer identifiable patient records unless expressly selected above and authorized.

Insurance Information (If Included)

Medical History Summary (Representative)

Permitted Use and Restrictions

Sponsor shall use Confidential Information and any received data solely for Sponsor's internal research, regulatory submissions, and authorized analyses expressly described in the Dataset Description. Sponsor shall not attempt to re-identify de-identified data or use identifiable PHI for marketing or any purpose not expressly permitted herein.

Any publication of aggregated results shall not include information that could reasonably identify an individual. Sponsor shall provide Provider a reasonable opportunity to review proposed publications that reference Provider's data and shall acknowledge Provider as required by Provider's institutional policy.

Data Security, Privacy and Breach Notification

Sponsor shall implement and maintain appropriate administrative, technical and physical safeguards to protect Confidential Information and any PHI received, consistent with applicable law. Such safeguards shall include, at a minimum, access controls, encryption for data at rest and in transit, and logging of access to sensitive data.

In the event of any security incident or unauthorized disclosure affecting PHI or Confidential Information, the discovering party shall notify the other party without undue delay but no later than 72 hours after discovery, provide a description of the incident and take commercially reasonable steps to contain and remediate the incident.

Data Return, Retention and Destruction

Upon expiration or termination of this Agreement, Sponsor shall, at Provider's option, return or securely destroy all Confidential Information and PHI provided by Provider, including all copies, extracts and derivative materials, within thirty (30) days unless retention is required by law or regulatory obligation.

Authorization Expiration Date:

Representations, Indemnification and Limitation of Liability

Each party represents that it has authority to enter into this Agreement. Provider represents that it has obtained or documented any patient authorizations required for disclosure of identifiable PHI. Sponsor agrees to indemnify, defend and hold harmless Provider from and against any third-party claims arising from Sponsor's misuse of data or failure to safeguard data as required in this Agreement.

Neither party shall be liable to the other for indirect, incidental, special or consequential damages except to the extent caused by willful misconduct or gross negligence.

Audit, Compliance and Recordkeeping

Provider shall have the right to audit Sponsor's compliance with the terms of this Agreement with reasonable prior notice and during normal business hours. Sponsor shall maintain records demonstrating compliance for a period of three (3) years following termination or longer where required by law.

Notices and Governing Law

Notices shall be provided in writing to the addresses designated by each party. This Agreement shall be governed by the laws of the state specified below.

Miscellaneous

This Agreement constitutes the entire agreement between the parties with respect to its subject matter and supersedes all prior agreements and understandings. Any amendment or modification must be in writing and executed by authorized representatives of both parties.

Sponsor:

By:

Date:

Title:

Healthcare Provider / Institution:

By:

Date:

Title:

Enter text✕

What the Healthcare Sponsor CDA Covers

The Healthcare Sponsor CDA is a confidential data agreement used when a study sponsor, research organization, or commercial sponsor obtains clinical, patient-level, or other health-related data from a healthcare provider or covered entity. It defines permitted uses, data categories, security controls, data return or destruction obligations, compliance with HIPAA privacy and security rules, and oversight rights such as audit and reporting. The agreement typically governs PHI handling, secondary use restrictions, data de-identification standards, and obligations after termination to ensure regulatory and contractual compliance.

Why a Sponsor CDA Matters for Clinical Data Sharing

A Sponsor CDA clarifies legal responsibilities for protected health information, limits downstream use, documents controls for data handling, and reduces regulatory and contractual uncertainty for both sponsor and provider.

Why a Sponsor CDA Matters for Clinical Data Sharing

Core Elements to Include in a Professional Sponsor CDA

A complete Sponsor CDA balances data access needs with privacy safeguards. Include precise definitions, security commitments, permitted uses, regulatory controls, and processes for breach response and audits.

Parties

Identify sponsor, healthcare provider, and any subcontractors by legal entity name, address, and role; include contact and legal representative details for notices.

Scope of Data

List exact data categories (PHI elements, dates, lab results, identifiers). Specify whether data is raw, de-identified, or limited dataset and relevant HIPAA rule references.

Permitted Uses

Describe allowed analyses, publication rights, secondary research limits, and prohibitions on re-identification or resale of patient data.

Security Measures

Specify technical and organizational safeguards: encryption, access controls, logging, MFA, incident response, and BAA requirements for covered entities.

Return or Destruction

State when and how data will be returned, destroyed, or retained after project end; include certificates of destruction or secure archival procedures.

Audit & Compliance

Allow auditing and monitoring rights, reporting cadence, obligations to cooperate with investigations, and remedies for noncompliance.

Step-by-Step: How to Complete the Sponsor CDA

Follow these steps in order to prepare a clear, enforceable agreement and reduce review cycles.

  • 01
    Assemble Parties: Confirm legal names and signatory authority for sponsor and provider.
  • 02
    Define Data: Detail data elements, format, and de-identification status.
  • 03
    Set Security: Specify controls, BAA requirements, and incident response terms.
  • 04
    Sign and Retain: Execute, date, and store the executed agreement with audit trail.

Configuring an Online Completion Workflow

Configure fields and authentication to reflect legal and security requirements when using an eSignature workflow.

Field Configuration
Document Upload Use PDF or DOCX; lock template after placement.
Signature Fields Add signature, date, and title fields; require all signers.
Authentication Enable email link plus optional SMS or KBA as required.
Audit Trail Capture IP, timestamps, and completion certificate.

Where to Send and Submit the Executed Sponsor CDA

Determine authoritative routing and archival locations before execution to ensure proper notice and recordkeeping.

  • Primary Recipient: Legal or contracts department email and postal address for service of notices.
  • Operational Copy: Project lead and data steward receive working copies for processing.
  • Security Archive: Store executed PDF in secure records repository with access controls.
  • Regulatory Filings: Provide copies to IRB or sponsor compliance office if required.

Technical Considerations for eSigning and eSubmission

Use an eSignature platform that supports audit trails, strong authentication, and secure storage for PHI.

  • File Formats: PDF, DOCX accepted
  • Integrations: Connect to clinical systems or cloud storage
  • Authentication: Email + SMS or MFA

Ensure the chosen platform can support a HIPAA Business Associate Agreement, provide tamper-evident signed PDFs, preserve audit logs, and integrate with enterprise systems for long-term retention and discovery.

Security and Compliance Requirements to Record in the CDA

Encryption: TLS 1.2/1.3 in transit
Data at Rest: AES-256 encryption
HIPAA BAA: BAA required for covered entities
Access Controls: Role-based access and MFA
Audit Trail: Timestamps, IP, and action log
Retention: Preserve signed records for discovery

Comparing eSignature Vendors for Healthcare Sponsor CDAs

Key vendor differences affect cost, bulk sending, HIPAA support, and envelope limits; signNow is listed first for direct comparison.

signNow DocuSign Adobe Sign PandaDoc HelloSign
Starting Price $8/user/mo $15/user/mo $14/user/mo $19/user/mo $15/user/mo
Free Trial 7-day free trial Available Available Available Available
Bulk Send Yes Yes Yes Yes No
Audit Trail Yes Yes Yes Yes Yes
HIPAA Compliant Yes Yes Yes No No
Envelope Cap No cap 100 envelopes/user/year Varies by plan Varies by plan Varies by plan

Penalties and Risks for an Incorrect or Noncompliant CDA

HIPAA Fines: Civil penalties and corrective action
Breach Liability: Notification costs and damages
Contract Termination: Loss of data access or funding
Regulatory Inspection: FDA or OCR inquiries possible
Research Delay: Delayed enrollment or analysis
Reputational Harm: Trust loss with participants

Common Mistakes to Avoid When Preparing a Sponsor CDA

  • Failing to specify exact data fields leads to disagreement over permitted datasets and increases re-identification risk.
  • Omitting BAA language or not obtaining a BAA when required creates HIPAA compliance gaps for covered entities.
  • Using vague purpose-of-use clauses permits unintended secondary use and complicates publication or transfer rights.
  • Neglecting to document retention and destruction procedures can cause noncompliance with HIPAA or study sponsor policies.

Who Typically Drafts, Reviews, and Signs a Sponsor CDA

Multiple stakeholders should be involved to ensure legal, clinical, and IT controls are aligned.

  • Contracts and legal teams: Draft and review terms to manage liability and regulatory obligations.
  • Data governance and IT: Validate security controls, access provisioning, and encryption standards.
  • Clinical operations or study managers: Confirm data elements, timelines, and operational feasibility.

Coordinate signatory authority up front; ensure the signer listed in the signature block has the corporate power to bind the organization.

Frequently Asked Questions About the Healthcare Sponsor CDA

Answers address signature validity, HIPAA considerations, electronic execution, amendment processes, and recordkeeping best practices.


Need help? Contact support

be ready to get more
Join over 28 million airSlate SignNow users